Argentina Swine Vaccines Market Size & Outlook, 2023-2030

The swine vaccines market in Argentina is expected to reach a projected revenue of US$ 11.3 million by 2030. A compound annual growth rate of 5.6% is expected of Argentina swine vaccines market from 2024 to 2030.
Revenue, 2023 (US$M)
$7.7
Forecast, 2030 (US$M)
$11.3
CAGR, 2024 - 2030
5.6%
Report Coverage
Argentina

Argentina swine vaccines market highlights

  • The Argentina swine vaccines market generated a revenue of USD 7.7 million in 2023 and is expected to reach USD 11.3 million by 2030.
  • The Argentina market is expected to grow at a CAGR of 5.6% from 2024 to 2030.
  • In terms of segment, inactivated (killed) was the largest revenue generating vaccine type in 2023.
  • Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids) is the most lucrative vaccine type segment registering the fastest growth during the forecast period.


Swine vaccines market data book summary

Market revenue in 2023USD 7.7 million
Market revenue in 2030USD 11.3 million
Growth rate5.6% (CAGR from 2023 to 2030)
Largest segmentInactivated (killed)
Fastest growing segmentOther Vaccines (e.g. Recombinant, DNA, subunit, or toxoids)
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationModified/ Attenuated Live, Inactivated (Killed), Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids)
Key market players worldwideMerck & Co Inc, CEVA Inc, Zoetis, Boehringer Ingelheim, Elanco Animal Health Inc, Indian Immunologicals, Biogenesis Bago, Phibro Animal Health Corp Class A, Virbac SA


Other key industry trends

  • In terms of revenue, Argentina accounted for 0.5% of the global swine vaccines market in 2023.
  • Country-wise, China is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil swine vaccines market is projected to lead the regional market in terms of revenue in 2030.
  • Mexico is the fastest growing regional market in Latin America and is projected to reach USD 45.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Swine Vaccines Market Companies

Name Profile # Employees HQ Website

Argentina swine vaccines market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to swine vaccines market will help companies and investors design strategic landscapes.


Inactivated (killed) was the largest segment with a revenue share of 37.66% in 2023. Horizon Databook has segmented the Argentina swine vaccines market based on modified/ attenuated live, inactivated (killed), other vaccines (e.g. recombinant, dna, subunit, or toxoids) covering the revenue growth of each sub-segment from 2018 to 2030.


The rising use of swine vaccines and launch of new products in Argentina are contributing to the market expansion. For example, HIPRA's innovative ERYSENG PARVO reproductive vaccine for swine, which offers excellent immunity against swine erysipelas and porcine parvovirus, has been launched in Argentina.

The SENG range of vaccines is now firmly established as the most advanced spectrum of vaccines for breeders with the introduction of ERYSENG PARVO in Argentina. Furthermore, growing prevalence of African swine fever across the country is boosting the demand for swine vaccines.

According to an article published by the European Food Agency, Senasa, the Argentine authority for health and food quality, declared a health alert across the country in 2021 due to African swine fever. This is the Buenos Aires government's response to the severe virus outbreak in the Dominican Republic and Haiti.

Reasons to subscribe to Argentina swine vaccines market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Argentina swine vaccines market databook

  • Our clientele includes a mix of swine vaccines market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Argentina swine vaccines market , including forecasts for subscribers. This country databook contains high-level insights into Argentina swine vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Argentina swine vaccines market size, by vaccine type, 2018-2030 (US$M)

Argentina Swine Vaccines Market Outlook Share, 2023 & 2030 (US$M)

Argentina swine vaccines market size, by vaccine type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more